A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17+ cell frequency

Patients with HPV-positive oropharyngeal squamous cell carcinomas (OPSCCs) have a better prognosis than patients with non-HPV-induced OPSCC. The role of the immune response in this phenomenon is yet unclear. We studied the number of T cells, regulatory T cells (Tregs), T helper 17 (Th17) cells and I...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Immunology, Immunotherapy Immunotherapy, 2016-04, Vol.65 (4), p.393-403
Hauptverfasser: Punt, Simone, Dronkers, Emilie A. C., Welters, Marij J. P., Goedemans, Renske, Koljenović, Senada, Bloemena, Elisabeth, Snijders, Peter J. F., Gorter, Arko, van der Burg, Sjoerd H., de Jong, Robert J. Baatenburg, Jordanova, Ekaterina S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 403
container_issue 4
container_start_page 393
container_title Cancer Immunology, Immunotherapy
container_volume 65
creator Punt, Simone
Dronkers, Emilie A. C.
Welters, Marij J. P.
Goedemans, Renske
Koljenović, Senada
Bloemena, Elisabeth
Snijders, Peter J. F.
Gorter, Arko
van der Burg, Sjoerd H.
de Jong, Robert J. Baatenburg
Jordanova, Ekaterina S.
description Patients with HPV-positive oropharyngeal squamous cell carcinomas (OPSCCs) have a better prognosis than patients with non-HPV-induced OPSCC. The role of the immune response in this phenomenon is yet unclear. We studied the number of T cells, regulatory T cells (Tregs), T helper 17 (Th17) cells and IL-17 + non-T cells (mainly granulocytes) in matched HPV-positive and HPV-negative OPSCC cases ( n  = 162). Furthermore, the production of IFN-γ and IL-17 by tumor-infiltrating T cells was analyzed. The number of tumor-infiltrating T cells and Tregs was higher in HPV-positive than HPV-negative OPSCC ( p  
doi_str_mv 10.1007/s00262-016-1805-x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4826411</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1779881624</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-283fba758424a6f5c05b17865a4be9f3c2ece3c06aa509ecbd3aa50cf8ad3a333</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhi0EokvhB3BBPiKhgL-SOBekquKj0kpcytmaeCe7rhJ7a29Kl9_Aj2ZWKRVcOHk088zrmXkZey3FeylE-6EIoRpVCdlU0oq6un_CVtJoythaPmUroY2oWiHMGXtRyg0FSnTdc3amGtt12toV-3XBe4w4BB9g5Id5SplPweeE8S7kFCeMBx4iTzntd5CPcYvEldsZpjQX7nEcuYfsQ0wT8EAZosAfMIefuOH9kQPfhe2OXy8sxA0f0w9-ta5k-27JDRlvZ4z--JI9G2As-OrhPWffP3-6vvxarb99ubq8WFfeGHWolNVDD21tjTLQDLUXdS9b29RgeuwG7RV61F40ALXo0PcbfYr8YIEirfU5-7jo7ud-wo2nHTOMbp_DRCu6BMH9W4lh57bpzhmrGiMlCbx9EMiJRi8HN4Vy2gUi0lmcbNvOWtkoQ6hcULppKRmHx2-kcCcX3eKiIxfdyUV3Tz1v_p7vseOPbQSoBShUIkuyu0lzjnSz_6j-BkaurFA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1779881624</pqid></control><display><type>article</type><title>A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17+ cell frequency</title><source>MEDLINE</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Punt, Simone ; Dronkers, Emilie A. C. ; Welters, Marij J. P. ; Goedemans, Renske ; Koljenović, Senada ; Bloemena, Elisabeth ; Snijders, Peter J. F. ; Gorter, Arko ; van der Burg, Sjoerd H. ; de Jong, Robert J. Baatenburg ; Jordanova, Ekaterina S.</creator><creatorcontrib>Punt, Simone ; Dronkers, Emilie A. C. ; Welters, Marij J. P. ; Goedemans, Renske ; Koljenović, Senada ; Bloemena, Elisabeth ; Snijders, Peter J. F. ; Gorter, Arko ; van der Burg, Sjoerd H. ; de Jong, Robert J. Baatenburg ; Jordanova, Ekaterina S.</creatorcontrib><description>Patients with HPV-positive oropharyngeal squamous cell carcinomas (OPSCCs) have a better prognosis than patients with non-HPV-induced OPSCC. The role of the immune response in this phenomenon is yet unclear. We studied the number of T cells, regulatory T cells (Tregs), T helper 17 (Th17) cells and IL-17 + non-T cells (mainly granulocytes) in matched HPV-positive and HPV-negative OPSCC cases ( n  = 162). Furthermore, the production of IFN-γ and IL-17 by tumor-infiltrating T cells was analyzed. The number of tumor-infiltrating T cells and Tregs was higher in HPV-positive than HPV-negative OPSCC ( p  &lt; 0.0001). In contrast, HPV-negative OPSCC contained significantly higher numbers of IL-17 + non-T cells ( p  &lt; 0.0001). Although a high number of intra-tumoral T cells showed a trend toward improved survival of all OPSCC patients, their prognostic effect in patients with a low number of intra-tumoral IL-17 + non-T cells was significant with regard to disease-specific ( p  = 0.033) and disease-free survival ( p  = 0.012). This suggests that a high frequency of IL-17 + non-T cells was related to a poor immune response, which was further supported by the observation that a high number of T cells was correlated with improved disease-free survival in the HPV-positive OPSCC ( p  = 0.008). In addition, we detected a minor Th17 cell population. However, T cells obtained from HPV-positive OPSCC produced significantly more IL-17 than those from HPV-negative tumors ( p  = 0.006). The improved prognosis of HPV-positive OPSCC is thus correlated with higher numbers of tumor-infiltrating T cells, more active Th17 cells and lower numbers of IL-17 + non-T cells.</description><identifier>ISSN: 0340-7004</identifier><identifier>EISSN: 1432-0851</identifier><identifier>DOI: 10.1007/s00262-016-1805-x</identifier><identifier>PMID: 26899388</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Cancer Research ; Carcinoma, Squamous Cell - complications ; Carcinoma, Squamous Cell - immunology ; CD3 Complex - immunology ; CD3 Complex - metabolism ; Female ; Forkhead Transcription Factors - immunology ; Forkhead Transcription Factors - metabolism ; Granulocytes - immunology ; Granulocytes - metabolism ; Humans ; Immunology ; Interleukin-17 - immunology ; Interleukin-17 - metabolism ; Kaplan-Meier Estimate ; Lymphocyte Count ; Male ; Medicine ; Medicine &amp; Public Health ; Microscopy, Confocal ; Middle Aged ; Oncology ; Original ; Original Article ; Oropharyngeal Neoplasms - complications ; Oropharyngeal Neoplasms - immunology ; Papillomaviridae - immunology ; Papillomavirus Infections - complications ; Papillomavirus Infections - immunology ; Papillomavirus Infections - virology ; T-Lymphocytes - immunology ; T-Lymphocytes - metabolism ; T-Lymphocytes, Regulatory - immunology ; T-Lymphocytes, Regulatory - metabolism ; Th17 Cells - immunology ; Th17 Cells - metabolism ; Tumor Microenvironment - immunology</subject><ispartof>Cancer Immunology, Immunotherapy, 2016-04, Vol.65 (4), p.393-403</ispartof><rights>The Author(s) 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-283fba758424a6f5c05b17865a4be9f3c2ece3c06aa509ecbd3aa50cf8ad3a333</citedby><cites>FETCH-LOGICAL-c442t-283fba758424a6f5c05b17865a4be9f3c2ece3c06aa509ecbd3aa50cf8ad3a333</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826411/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826411/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,41487,42556,51318,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26899388$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Punt, Simone</creatorcontrib><creatorcontrib>Dronkers, Emilie A. C.</creatorcontrib><creatorcontrib>Welters, Marij J. P.</creatorcontrib><creatorcontrib>Goedemans, Renske</creatorcontrib><creatorcontrib>Koljenović, Senada</creatorcontrib><creatorcontrib>Bloemena, Elisabeth</creatorcontrib><creatorcontrib>Snijders, Peter J. F.</creatorcontrib><creatorcontrib>Gorter, Arko</creatorcontrib><creatorcontrib>van der Burg, Sjoerd H.</creatorcontrib><creatorcontrib>de Jong, Robert J. Baatenburg</creatorcontrib><creatorcontrib>Jordanova, Ekaterina S.</creatorcontrib><title>A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17+ cell frequency</title><title>Cancer Immunology, Immunotherapy</title><addtitle>Cancer Immunol Immunother</addtitle><addtitle>Cancer Immunol Immunother</addtitle><description>Patients with HPV-positive oropharyngeal squamous cell carcinomas (OPSCCs) have a better prognosis than patients with non-HPV-induced OPSCC. The role of the immune response in this phenomenon is yet unclear. We studied the number of T cells, regulatory T cells (Tregs), T helper 17 (Th17) cells and IL-17 + non-T cells (mainly granulocytes) in matched HPV-positive and HPV-negative OPSCC cases ( n  = 162). Furthermore, the production of IFN-γ and IL-17 by tumor-infiltrating T cells was analyzed. The number of tumor-infiltrating T cells and Tregs was higher in HPV-positive than HPV-negative OPSCC ( p  &lt; 0.0001). In contrast, HPV-negative OPSCC contained significantly higher numbers of IL-17 + non-T cells ( p  &lt; 0.0001). Although a high number of intra-tumoral T cells showed a trend toward improved survival of all OPSCC patients, their prognostic effect in patients with a low number of intra-tumoral IL-17 + non-T cells was significant with regard to disease-specific ( p  = 0.033) and disease-free survival ( p  = 0.012). This suggests that a high frequency of IL-17 + non-T cells was related to a poor immune response, which was further supported by the observation that a high number of T cells was correlated with improved disease-free survival in the HPV-positive OPSCC ( p  = 0.008). In addition, we detected a minor Th17 cell population. However, T cells obtained from HPV-positive OPSCC produced significantly more IL-17 than those from HPV-negative tumors ( p  = 0.006). The improved prognosis of HPV-positive OPSCC is thus correlated with higher numbers of tumor-infiltrating T cells, more active Th17 cells and lower numbers of IL-17 + non-T cells.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Cancer Research</subject><subject>Carcinoma, Squamous Cell - complications</subject><subject>Carcinoma, Squamous Cell - immunology</subject><subject>CD3 Complex - immunology</subject><subject>CD3 Complex - metabolism</subject><subject>Female</subject><subject>Forkhead Transcription Factors - immunology</subject><subject>Forkhead Transcription Factors - metabolism</subject><subject>Granulocytes - immunology</subject><subject>Granulocytes - metabolism</subject><subject>Humans</subject><subject>Immunology</subject><subject>Interleukin-17 - immunology</subject><subject>Interleukin-17 - metabolism</subject><subject>Kaplan-Meier Estimate</subject><subject>Lymphocyte Count</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Microscopy, Confocal</subject><subject>Middle Aged</subject><subject>Oncology</subject><subject>Original</subject><subject>Original Article</subject><subject>Oropharyngeal Neoplasms - complications</subject><subject>Oropharyngeal Neoplasms - immunology</subject><subject>Papillomaviridae - immunology</subject><subject>Papillomavirus Infections - complications</subject><subject>Papillomavirus Infections - immunology</subject><subject>Papillomavirus Infections - virology</subject><subject>T-Lymphocytes - immunology</subject><subject>T-Lymphocytes - metabolism</subject><subject>T-Lymphocytes, Regulatory - immunology</subject><subject>T-Lymphocytes, Regulatory - metabolism</subject><subject>Th17 Cells - immunology</subject><subject>Th17 Cells - metabolism</subject><subject>Tumor Microenvironment - immunology</subject><issn>0340-7004</issn><issn>1432-0851</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><recordid>eNp9kU1v1DAQhi0EokvhB3BBPiKhgL-SOBekquKj0kpcytmaeCe7rhJ7a29Kl9_Aj2ZWKRVcOHk088zrmXkZey3FeylE-6EIoRpVCdlU0oq6un_CVtJoythaPmUroY2oWiHMGXtRyg0FSnTdc3amGtt12toV-3XBe4w4BB9g5Id5SplPweeE8S7kFCeMBx4iTzntd5CPcYvEldsZpjQX7nEcuYfsQ0wT8EAZosAfMIefuOH9kQPfhe2OXy8sxA0f0w9-ta5k-27JDRlvZ4z--JI9G2As-OrhPWffP3-6vvxarb99ubq8WFfeGHWolNVDD21tjTLQDLUXdS9b29RgeuwG7RV61F40ALXo0PcbfYr8YIEirfU5-7jo7ud-wo2nHTOMbp_DRCu6BMH9W4lh57bpzhmrGiMlCbx9EMiJRi8HN4Vy2gUi0lmcbNvOWtkoQ6hcULppKRmHx2-kcCcX3eKiIxfdyUV3Tz1v_p7vseOPbQSoBShUIkuyu0lzjnSz_6j-BkaurFA</recordid><startdate>20160401</startdate><enddate>20160401</enddate><creator>Punt, Simone</creator><creator>Dronkers, Emilie A. C.</creator><creator>Welters, Marij J. P.</creator><creator>Goedemans, Renske</creator><creator>Koljenović, Senada</creator><creator>Bloemena, Elisabeth</creator><creator>Snijders, Peter J. F.</creator><creator>Gorter, Arko</creator><creator>van der Burg, Sjoerd H.</creator><creator>de Jong, Robert J. Baatenburg</creator><creator>Jordanova, Ekaterina S.</creator><general>Springer Berlin Heidelberg</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160401</creationdate><title>A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17+ cell frequency</title><author>Punt, Simone ; Dronkers, Emilie A. C. ; Welters, Marij J. P. ; Goedemans, Renske ; Koljenović, Senada ; Bloemena, Elisabeth ; Snijders, Peter J. F. ; Gorter, Arko ; van der Burg, Sjoerd H. ; de Jong, Robert J. Baatenburg ; Jordanova, Ekaterina S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-283fba758424a6f5c05b17865a4be9f3c2ece3c06aa509ecbd3aa50cf8ad3a333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Cancer Research</topic><topic>Carcinoma, Squamous Cell - complications</topic><topic>Carcinoma, Squamous Cell - immunology</topic><topic>CD3 Complex - immunology</topic><topic>CD3 Complex - metabolism</topic><topic>Female</topic><topic>Forkhead Transcription Factors - immunology</topic><topic>Forkhead Transcription Factors - metabolism</topic><topic>Granulocytes - immunology</topic><topic>Granulocytes - metabolism</topic><topic>Humans</topic><topic>Immunology</topic><topic>Interleukin-17 - immunology</topic><topic>Interleukin-17 - metabolism</topic><topic>Kaplan-Meier Estimate</topic><topic>Lymphocyte Count</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Microscopy, Confocal</topic><topic>Middle Aged</topic><topic>Oncology</topic><topic>Original</topic><topic>Original Article</topic><topic>Oropharyngeal Neoplasms - complications</topic><topic>Oropharyngeal Neoplasms - immunology</topic><topic>Papillomaviridae - immunology</topic><topic>Papillomavirus Infections - complications</topic><topic>Papillomavirus Infections - immunology</topic><topic>Papillomavirus Infections - virology</topic><topic>T-Lymphocytes - immunology</topic><topic>T-Lymphocytes - metabolism</topic><topic>T-Lymphocytes, Regulatory - immunology</topic><topic>T-Lymphocytes, Regulatory - metabolism</topic><topic>Th17 Cells - immunology</topic><topic>Th17 Cells - metabolism</topic><topic>Tumor Microenvironment - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Punt, Simone</creatorcontrib><creatorcontrib>Dronkers, Emilie A. C.</creatorcontrib><creatorcontrib>Welters, Marij J. P.</creatorcontrib><creatorcontrib>Goedemans, Renske</creatorcontrib><creatorcontrib>Koljenović, Senada</creatorcontrib><creatorcontrib>Bloemena, Elisabeth</creatorcontrib><creatorcontrib>Snijders, Peter J. F.</creatorcontrib><creatorcontrib>Gorter, Arko</creatorcontrib><creatorcontrib>van der Burg, Sjoerd H.</creatorcontrib><creatorcontrib>de Jong, Robert J. Baatenburg</creatorcontrib><creatorcontrib>Jordanova, Ekaterina S.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer Immunology, Immunotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Punt, Simone</au><au>Dronkers, Emilie A. C.</au><au>Welters, Marij J. P.</au><au>Goedemans, Renske</au><au>Koljenović, Senada</au><au>Bloemena, Elisabeth</au><au>Snijders, Peter J. F.</au><au>Gorter, Arko</au><au>van der Burg, Sjoerd H.</au><au>de Jong, Robert J. Baatenburg</au><au>Jordanova, Ekaterina S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17+ cell frequency</atitle><jtitle>Cancer Immunology, Immunotherapy</jtitle><stitle>Cancer Immunol Immunother</stitle><addtitle>Cancer Immunol Immunother</addtitle><date>2016-04-01</date><risdate>2016</risdate><volume>65</volume><issue>4</issue><spage>393</spage><epage>403</epage><pages>393-403</pages><issn>0340-7004</issn><eissn>1432-0851</eissn><abstract>Patients with HPV-positive oropharyngeal squamous cell carcinomas (OPSCCs) have a better prognosis than patients with non-HPV-induced OPSCC. The role of the immune response in this phenomenon is yet unclear. We studied the number of T cells, regulatory T cells (Tregs), T helper 17 (Th17) cells and IL-17 + non-T cells (mainly granulocytes) in matched HPV-positive and HPV-negative OPSCC cases ( n  = 162). Furthermore, the production of IFN-γ and IL-17 by tumor-infiltrating T cells was analyzed. The number of tumor-infiltrating T cells and Tregs was higher in HPV-positive than HPV-negative OPSCC ( p  &lt; 0.0001). In contrast, HPV-negative OPSCC contained significantly higher numbers of IL-17 + non-T cells ( p  &lt; 0.0001). Although a high number of intra-tumoral T cells showed a trend toward improved survival of all OPSCC patients, their prognostic effect in patients with a low number of intra-tumoral IL-17 + non-T cells was significant with regard to disease-specific ( p  = 0.033) and disease-free survival ( p  = 0.012). This suggests that a high frequency of IL-17 + non-T cells was related to a poor immune response, which was further supported by the observation that a high number of T cells was correlated with improved disease-free survival in the HPV-positive OPSCC ( p  = 0.008). In addition, we detected a minor Th17 cell population. However, T cells obtained from HPV-positive OPSCC produced significantly more IL-17 than those from HPV-negative tumors ( p  = 0.006). The improved prognosis of HPV-positive OPSCC is thus correlated with higher numbers of tumor-infiltrating T cells, more active Th17 cells and lower numbers of IL-17 + non-T cells.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>26899388</pmid><doi>10.1007/s00262-016-1805-x</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0340-7004
ispartof Cancer Immunology, Immunotherapy, 2016-04, Vol.65 (4), p.393-403
issn 0340-7004
1432-0851
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4826411
source MEDLINE; PubMed Central; SpringerLink Journals - AutoHoldings
subjects Adult
Aged
Aged, 80 and over
Cancer Research
Carcinoma, Squamous Cell - complications
Carcinoma, Squamous Cell - immunology
CD3 Complex - immunology
CD3 Complex - metabolism
Female
Forkhead Transcription Factors - immunology
Forkhead Transcription Factors - metabolism
Granulocytes - immunology
Granulocytes - metabolism
Humans
Immunology
Interleukin-17 - immunology
Interleukin-17 - metabolism
Kaplan-Meier Estimate
Lymphocyte Count
Male
Medicine
Medicine & Public Health
Microscopy, Confocal
Middle Aged
Oncology
Original
Original Article
Oropharyngeal Neoplasms - complications
Oropharyngeal Neoplasms - immunology
Papillomaviridae - immunology
Papillomavirus Infections - complications
Papillomavirus Infections - immunology
Papillomavirus Infections - virology
T-Lymphocytes - immunology
T-Lymphocytes - metabolism
T-Lymphocytes, Regulatory - immunology
T-Lymphocytes, Regulatory - metabolism
Th17 Cells - immunology
Th17 Cells - metabolism
Tumor Microenvironment - immunology
title A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17+ cell frequency
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T20%3A28%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20beneficial%20tumor%20microenvironment%20in%20oropharyngeal%20squamous%20cell%20carcinoma%20is%20characterized%20by%20a%20high%20T%20cell%20and%20low%20IL-17+%20cell%20frequency&rft.jtitle=Cancer%20Immunology,%20Immunotherapy&rft.au=Punt,%20Simone&rft.date=2016-04-01&rft.volume=65&rft.issue=4&rft.spage=393&rft.epage=403&rft.pages=393-403&rft.issn=0340-7004&rft.eissn=1432-0851&rft_id=info:doi/10.1007/s00262-016-1805-x&rft_dat=%3Cproquest_pubme%3E1779881624%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1779881624&rft_id=info:pmid/26899388&rfr_iscdi=true